Spironolactone Bodies in Aldosteronomas and in the Attached Adrenals. Enzyme Histochemical Study of 19 Cases of Primary Aldosteronism and a Case of Aldosteronism Due to Bilateral Diffuse Hyperplasia of the Zona Glomerulosa

Overview

Journal Am J Pathol

Publisher Elsevier

Specialty Pathology

Date 1981 Jun 1

PMID 7195152

Citations 7

Authors

M Aiba

H Suzuki

K Kageyama

M Murai

H Tazaki

O Abe

T Saruta

Affiliations

Soon will be listed here.

Abstract

The formation of spironolactone (S) bodies, eosinophilic laminated cytoplasmic inclusions, is induced in the aldosterone-producing cells of the human adrenal cortex after the administration of spironolactone. The aim of this study was to define the enzyme histochemical characteristics of S bodies, S-body-containing cells, and the apparently hyperplastic zona glomerulosa (zG) of adrenal tissues attached to aldosteronomas. S bodies were found in 14 of 19 aldosteronomas, in 10 of 19 adrenal tissues attached to aldosteronomas, and in the adrenal tissues in a patient with aldosteronism due to bilateral diffuse zG hyperplasia. The S bodies themselves exhibited most intense 3 beta-hydroxysteroid dehydrogenase (3 beta HSD) activity but did not exhibit glucose-6-phosphate dehydrogenase (G6PD), NADP-dependent isocitrate dehydrogenase (NADP-ICDH), or succinate dehydrogenase (SDH) activity, confirming histochemically the origin of S bodies in the smooth endoplasmic reticulum. In two adenomas, S bodies were found to be surrounded by reaction products of acid hydrolase but were not found in the other adenomas and the remaining adrenal tissues. S-body-containing cells, irrespective of being neoplastic or not, showed enhanced 3 beta HSD, G6PD, and NADP-ICDH activity and weak SDH activity (Type I pattern of enzyme activity). Though zG was hyperplastic in most of the adrenal tissues attached to the adenomas, zG cells that did not contain S bodies showed the opposite pattern (Type II pattern) of enzyme activity (ie, weak 3 beta HSD, G6PD, and NADP-ICDH activity and intense SDH activity), in contrast to those in the adrenal tissues in a patient with aldosteronism due to bilateral diffuse zG hyperplasia (which showed the Type I pattern). The results are consistent with the view that hyperplastic zG cells, except S-body-containing cells, in the case of aldosteronoma are not hyperfunctioning. The latter cells may have enhanced but possibly abortive steroidogenic activity.

Citing Articles

Spontaneous Remission of Primary Aldosteronism with Mineralocorticoid Receptor Antagonist Therapy: A Review.

Mai X, Kometani M, Yoneda T Int J Mol Sci. 2022; 23(22).

PMID: 36430298 PMC: 9698409. DOI: 10.3390/ijms232213821.

Mineralocorticoid Receptor Antagonists Eplerenone and Spironolactone Modify Adrenal Cortex Morphology and Physiology.

Pereira S, Carvalho L, Costa M, Melo A, Ferreira I, Gomez-Sanchez C Biomedicines. 2021; 9(4).

PMID: 33924172 PMC: 8074383. DOI: 10.3390/biomedicines9040441.

Adrenal gland inclusions in patients treated with aldosterone antagonists (Spironolactone/Eplerenone): incidence, morphology, and ultrastructural findings.

Patel K, Calomeni E, Nadasdy T, Zynger D Diagn Pathol. 2014; 9:147.

PMID: 25108298 PMC: 4261889. DOI: 10.1186/1746-1596-9-147.

The value of losartan suppression test in the confirmatory diagnosis of primary aldosteronism in patients over 50 years old.

Kuo C, Balakrishnan P, Hsein Y, Wu V, Jeff Chueh S, Chen Y J Renin Angiotensin Aldosterone Syst. 2014; 16(3):587-98.

PMID: 25031295 PMC: 4297265. DOI: 10.1177/1470320313498632.

Alteration of subcapsular adrenocortical zonation in humans with aging: the progenitor zone predominates over the previously well-developed zona glomerulosa after 40 years of age.

Aiba M, Fujibayashi M J Histochem Cytochem. 2011; 59(5):557-64.

PMID: 21411711 PMC: 3201174. DOI: 10.1369/0022155411404071.

References

CONN J, HINERMAN D . Spironolactone-induced inhibition of aldosterone biosynthesis in primary aldosteronism: morphological and functional studies. Metabolism. 1977; 26(12):1293-307. DOI: 10.1016/0026-0495(77)90026-9. View

Shrago S, Waisman J, Cooper P . Spironolactone bodies in an adrenal adenoma. Arch Pathol. 1975; 99(8):416-20. View

Sundsfjord J, Marton P, Jorgensen H, AAKVAAG A . Reduced aldosterone secretion during spironolactone treatment in primary aldosteronism: report of a case. J Clin Endocrinol Metab. 1974; 39(4):734-9. DOI: 10.1210/jcem-39-4-734. View

Cheng S, Suzuki K, Sadee W, HARDING B . Effects of spironolactone, canrenone and canrenoate-K on cytochrome P450, and 11beta- and 18-hydroxylation in bovine and human adrenal cortical mitochondria. Endocrinology. 1976; 99(4):1097-106. DOI: 10.1210/endo-99-4-1097. View

CAIN D, VAN DE VELDE R, Shapiro S . Spironolactone inclusions in an aldosteronoma. Am J Clin Pathol. 1974; 61(3):412-6. DOI: 10.1093/ajcp/61.3.412. View

Okano K, Matsumoto K, Koizumi T, Mizushima T, Mori M . Histochemical comparison of oxidative enzymes in adrenal glands of mammals. Histochemie. 1965; 4(6):494-501. DOI: 10.1007/BF00281902. View

Hayashi M . HISTOCHEMICAL DEMONSTRATION OF N-ACETYL-BETA-GLUCOSAMINIDASE EMPLOYING NAPHTHOL AS-BI N-ACETYL-BETA -GLUCOSAMINIDE AS SUBSTRATE. J Histochem Cytochem. 1965; 13:355-60. DOI: 10.1177/13.5.355. View

Erbler H . The effect of saluretics and spironolactone on aldosterone production and electrolyte excretion in man. Naunyn Schmiedebergs Arch Pharmacol. 1974; 286(2):145-56. DOI: 10.1007/BF00501608. View

Aiba M, Kameya T, Suzuki H, Nakamura H, Mizuno Y, Kanno T . Enzyme histochemical and electron microscopic study of a virilizing adrenocortical adenoma. Acta Pathol Jpn. 1978; 28(4):615-26. DOI: 10.1111/j.1440-1827.1978.tb00900.x. View

10.

WATTENBERG L . Microscopic histochemical demonstration of steroid-3 beta-ol dehydrogenase in tissue sections. J Histochem Cytochem. 1958; 6(4):225-32. DOI: 10.1177/6.4.225. View

11.

Janigan D . Cytoplasmic bodies in the adrenal cortex of patients treated with spirolactone. Lancet. 1963; 1(7286):850-2. DOI: 10.1016/s0140-6736(63)91624-6. View

12.

NACHLAS M, TSOU K, De Souza E, Cheng C, Seligman A . Cytochemical demonstration of succinic dehydrogenase by the use of a new p-nitrophenyl substituted ditetrazole. J Histochem Cytochem. 1957; 5(4):420-36. DOI: 10.1177/5.4.420. View

13.

Kovacs K, Horvath E, Singer W . Fine structure and morphogenesis of spironolactone bodies in the zona glomerulosa of the human adrenal cortex. J Clin Pathol. 1973; 26(12):949-57. PMC: 477936. DOI: 10.1136/jcp.26.12.949. View

14.

Hayashi M, Nakajima Y, FISHMAN W . THE CYTOLOGIC DEMONSTRATION OF BETA-GLUCURONIDASE EMPLOYING NAPHTHOL AS-BI GLUCURONIDE AND HEXAZONIUM PARAROSANILIN; A PRELIMINARY REPORT. J Histochem Cytochem. 1964; 12:293-7. DOI: 10.1177/12.4.293. View

15.

Mori M . Histochemical evaluation of NADP-dependent glucose-6-phosphate and isocitrate dehydrogenases in steroid producing organs and tumors. Arch Histol Jpn. 1967; 28(1):45-57. DOI: 10.1679/aohc1950.28.45. View

16.

BURSTONE M, Keyes P . Studies on calcification. I. The effect of inhibition of enzyme activity on developing bone and dentin. Am J Pathol. 1957; 33(6):1229-35. PMC: 1934667. View

17.

Jenis E, Hertzog R . Effect of spironolactone on the zona. Light and electron microscopy. Arch Pathol. 1969; 88(5):530-9. View

18.

Davis D, Medline N . Spironolactone (aldactone) bodies: concentric lamellar formations in the adrenal cortices of patients treated with spironolactone. Am J Clin Pathol. 1970; 54(1):22-32. DOI: 10.1093/ajcp/54.1.22. View

19.

Headon D, Hsiao J, Ungar F . The intracellular localization of adrenal 3beta-hydroxysteroid dehydrogenase/delta5-isomerase by density gradient perturbation. Biochem Biophys Res Commun. 1978; 82(3):1006-12. DOI: 10.1016/0006-291x(78)90883-5. View